These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21427648)

  • 41. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
    Sinha S; Frishman WH
    J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E; Bland M; Thompson M; Jahangiri M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
    Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?
    van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B; Głowińska B; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2.
    Zhou SF; Hu SY; Ma L; Miao L; Mao WZ
    Chin Med J (Engl); 2013; 126(10):1925-9. PubMed ID: 23673111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
    Boyum J; Fellinger EK; Schmoker JD; Trombley L; McPartland K; Ittleman FP; Howard AB
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):686-91. PubMed ID: 15001896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
    Petersen E; Wågberg F; Angquist KA
    Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinase imbalance in inguinal hernia formation.
    Antoniou GA; Tentes IK; Antoniou SA; Simopoulos C; Lazarides MK
    J Invest Surg; 2011; 24(4):145-50. PubMed ID: 21675849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2.
    Rossignol P; Jacob MP; Cambillau M; Mouradian D; Plouin PF; Chatellier G
    Thromb Res; 2007; 119(2):261-3. PubMed ID: 16530811
    [No Abstract]   [Full Text] [Related]  

  • 54. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
    Ishii T; Asuwa N
    Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
    Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
    Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of insertion/deletion polymorphism of the angiotensin-converting enzyme gene in abdominal aortic aneurysm and inguinal hernia.
    Antoniou GA; Lazarides MK; Patera S; Antoniou SA; Giannoukas AD; Georgiadis GS; Veletza SV
    Vascular; 2013 Feb; 21(1):1-5. PubMed ID: 22271804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer.
    Rauvala M; Turpeenniemi-Hujanen T; Puistola U
    Anticancer Res; 2006; 26(6C):4779-84. PubMed ID: 17214341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
    Tousoulis D; Andreou I; Tentolouris C; Antoniades C; Papageorgiou N; Gounari P; Kotrogiannis I; Miliou A; Charakida M; Trikas A; Stefanadis C
    Int J Cardiol; 2010 Dec; 145(3):438-43. PubMed ID: 19539384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.